An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH	cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder	Recruiting	Not stated	2026-06-26		NCT06129240

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Liquidia Technologies, Inc.	7

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Advent Health	Orlando	United States	14
Arizona Pulmonary Specialists	Phoenix	United States	2
Hartford Hospital	Hartford	United States	131
Houston Methodist	Houston	United States	63
Medical University of South Carolina	Charleston	United States	628
National Jewish Health	Denver	United States	72
Norton Pulmonary Specialists	Louisville	United States	1
NYU Langone Medical Center	New York	United States	32
Summit Health	Bend	United States	5
Tampa General Hospital Center of Research Excellence	Tampa	United States	1
The Medical Research Group, Inc.	Fresno	United States	3
Tufts Medical Center	Boston	United States	238
UC Davis	Sacremento	United States	1
UCLA Westwood	Los Angeles	United States	2
UCSF	San Francisco	United States	27
University of California San Diego	La Jolla	United States	54
University of Cincinnati Health	Cincinnati	United States	1
University of Michigan	Ann Arbor	United States	538
University of Minnesota	Minneapolis	United States	325
University of North Carolina At Chapel Hill	Chapel Hill	United States	50
University of Rochester	Rochester	United States	10
University of Utah	Salt Lake City	United States	137
Vincent Medical Group	Indianapolis	United States	1

Clinical trials